Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

Albuterol and Immune Cell Composition
Condition:   Immune Cell Composition Intervention:   Drug: Administration of albuterol Sponsor:   University of Arizona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2019 Category: Research Source Type: clinical trials

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
Condition:   Asthma Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Budesonide metered-dose inhaler 160 µg;   Combination Product: Albuterol sulfate metered-dose inhale r 180 μg;   Combination Product: Placebo metered-dose inhaler Sponsor:   Bond Avillion 2 Development LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2019 Category: Research Source Type: clinical trials

The Effect of NAC on Lung Function and CT Mucus Score
Condition:   Asthma Interventions:   Drug: n-acetylcystine + albuterol;   Drug: 0.9% saline + albuterol Sponsor:   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2019 Category: Research Source Type: clinical trials

A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately.
Condition:   Healthy Volunteers Interventions:   Drug: Treatment A (Budesonide/Albuterol Sulfate metered dose inhaler);   Drug: Treatment B (Budesonide metered dose inhaler);   Drug: Treatment C (Albuterol Sulfate metered dose inhaler) Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials

A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
Condition:   Asthma Interventions:   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 80/180 μg;   Combination Product: Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg;   Combination Product: Albuterol sulfate metered-dose inhaler 180 μg Sponsor:   Bond Avillion 2 Development LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2018 Category: Research Source Type: clinical trials